Abel Eraso-Pichot

Abel Eraso-Pichot

Auto-generated profile, based on publicly available information

Abel Eraso-Pichot

Laboratory of Molecular Physiology and Channelopathies, Departament de Ciències Experimentals i de la Salut (DCEXS), Universitat Pompeu Fabra (UPF), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2014 in Molecular Membrane Biology
Verified
Journal Article
Closed access
MTMarta Tajes
Marta Tajes
EREva Ramos-Fernández
Eva Ramos-Fernández
XWXian Weng-Jiang
Xian Weng-Jiang
MBMònica Bosch-Morató
Mònica Bosch-Morató
BGBiuse Guivernau
Biuse Guivernau
FMFrancisco J. Muñoz
Francisco J. Muñoz
The blood-brain barrier (BBB) is constituted by a specialized vascular endothelium that interacts directly with astrocytes, neurons and pericytes. It protects the brain from the molecules of the systemic circulation but it has to be overcome for the proper treatment of brain cancer, psychiatric disorders or neurodegenerative diseases, which are dramatically increasing as the population ages. In the present work we have revised the current knowledge on the cellular structure of the BBB and the different procedures utilized currently and those proposed to cross it. Chemical modifications of the drugs, such as increasing their lipophilicity, turn them more prone to be internalized in the brain. Other mechanisms are the use of molecular tools to bind the drugs such as small immunoglobulins, liposomes or nanoparticles that will act as Trojan Horses favoring the drug delivery in brain. This fusion of the classical pharmacology with nanotechnology has opened a wide field to many different approaches with promising results to hypothesize that BBB will not be a major problem for the new generation of neuroactive drugs. The present review provides an overview of all state-of-the-art of the BBB structure and function, as well as of the classic strategies and these appeared in recent years to deliver drugs into the brain for the treatment of Central Nervous System (CNS) diseases.

2 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
PHPhilip Hasel
Philip Hasel
ODOwen Dando
Owen Dando
ZJZoeb Jiwaji
Zoeb Jiwaji
PBPaul Baxter
Paul Baxter
ATAlison Todd
Alison Todd
GHGiles Hardingham
Giles Hardingham
The influence that neurons exert on astrocytic function is poorly understood. To investigate this, we first developed a system combining cortical neurons and astrocytes from closely related species, followed by RNA-seq and in silico species separation. This approach uncovers a wide programme of neuron-induced astrocytic gene expression, involving Notch signalling, which drives and maintains astrocytic maturity and neurotransmitter uptake function, is conserved in human development, and is disrupted by neurodegeneration. Separately, hundreds of astrocytic genes are acutely regulated by synaptic activity via mechanisms involving cAMP/PKA-dependent CREB activation. This includes the coordinated activity-dependent upregulation of major astrocytic components of the astrocyte–neuron lactate shuttle, leading to a CREB-dependent increase in astrocytic glucose metabolism and elevated lactate export. Moreover, the groups of astrocytic genes induced by neurons or neuronal activity both show age-dependent decline in humans. Thus, neurons and neuronal activity regulate the astrocytic transcriptome with the potential to shape astrocyte–neuron metabolic cooperation.

25 March 2018 in Glia
Verified
Journal Article
Closed access
PDF file
AEAbel Eraso‐Pichot
Abel Eraso‐Pichot
MBMarina Brasó‐Vives
Marina Brasó‐Vives
AGArantxa Golbano
Arantxa Golbano
CMCarmen Menacho
Carmen Menacho
ECEnrique Claro
Enrique Claro
RMRoser Masgrau
Roser Masgrau

6 May 2019 in Glia
Verified
Journal Article
Closed access
PDF file
KKKsenia V. Kastanenka
Ksenia V. Kastanenka
RBRubén Moreno Bote
Rubén Moreno Bote
MPMaurizio De Pittà
Maurizio De Pittà
Gertrudis PereaGertrudis Perea
Gertrudis Perea
AEAbel Eraso‐Pichot
Abel Eraso‐Pichot
EGElena Galea
Elena Galea

13 July 2022 in Glia
Verified
Journal Article
Open access
AEAbel Eraso‐Pichot
Abel Eraso‐Pichot
SPSandrine Pouvreau
Sandrine Pouvreau
AOAlexandre Olivera‐Pinto
Alexandre Olivera‐Pinto
PGPaula Gomez‐Sotres
Paula Gomez‐Sotres
USUrszula Skupio
Urszula Skupio
GMGiovanni Marsicano
Giovanni Marsicano
The study of the astrocytic contribution to brain functions has been growing in popularity in the neuroscience field. In the last years, and especially since the demonstration of the involvement of astrocytes in synaptic functions, the astrocyte field has revealed multiple functions of these cells that seemed inconceivable not long ago. In parallel, cannabinoid investigation has also identified different ways by which cannabinoids are able to interact with these cells, modify their functions, alter their communication with neurons and impact behavior. In this review, we will describe the expression of different endocannabinoid system members in astrocytes. Moreover, we will relate the latest findings regarding cannabinoid modulation of some of the most relevant astroglial functions, namely calcium (Ca2+) dynamics, gliotransmission, metabolism, and inflammation.

1 September 2021 in Neuropharmacology
Verified
Journal Article
Closed access
ACAna Covelo
Ana Covelo
AEAbel Eraso-Pichot
Abel Eraso-Pichot
IMIgnacio Fernández Moncada
Ignacio Fernández Moncada
RSRomán Serrat
Román Serrat
GMGiovanni Marsicano
Giovanni Marsicano